معرفی
Andrew Perkins is a Professor at the Australian Centre for Blood Diseases, part of the School of Translational Medicine, Monash University. He is also the Head of Genomic Medicine at Alfred Health and Professor of Haematology at The Alfred Hospital, Melbourne, where he integrates clinical practice with cutting-edge research in blood diseases.
His research centers on transcriptional control networks in blood stem cells and blood cancers, with a focus on JAK-STAT signaling, erythropoiesis, and genomic mechanisms of inherited blood disorders. He leads projects in gene editing and personalized medicine for blood cancers. His work bridges basic science and clinical application, aiming to develop cures for both inherited and acquired blood diseases.
His recent publications highlight his work in γ-globin gene regulation, diagnostic variability in myeloproliferative neoplasms, congenital fibrinogen disorders, and genotype-phenotype correlations. These reflect a consistent focus on genomic medicine, transcriptional regulation, and precision diagnostics.
- Albert G. Baikie Memorial Medal
- AMRAD Postdoctoral Award
- Logan Research Fellowship
- Lucille P. Markey Postdoctoral Research Fellowship
- Medical Postgraduate Research Fellowship
Professor Perkins has extensive supervisory experience, having mentored 26 PhD students, 25 BSc Hons students, and several Masters students. He contributes to teaching in Haematological Malignancies (HUP3022) and the Masters of Genome Analytics. He is actively involved in national initiatives such as the Australia Leukaemia and Lymphoma Group and the Lorne Genome Conference Organising Committee, and has served on NHMRC review panels.
He is a key figure in clinical genomics and blood cancer research in Australia, leading impactful translational projects and fostering collaboration across institutions.
